CorTec GmbH, a leader in innovative implantable technologies, is pleased to announce a strategic partnership with Heraeus Medevio, based in Minneapolis, USA. This collaboration aims to support customers in the neuromodulation sector, from concept and small series production (CorTec) to large series production (Medevio). Together, the companies will deliver next-generation medical devices and drive innovation globally with a strong partnership across oceans.
The partnership between Medevio and CorTec combines Medevio’s advanced production capabilities with CorTec’s expertise in the development, prototyping and small series production for nerve cuff and paddle electrodes, capable of sensing and stimulation. Together, they will address the neuromodulation market’s growing demand for innovative, high-quality implantable components. Medevio will refer early-phase complex prototype development projects for cuff and paddle electrodes to CorTec, while CorTec will leverage Medevio’s exclusive capabilities to scale production efficiently for high-volume manufacturing of such electrodes.
This unique synergy reinforces both companies’ commitment to providing unparalleled quality, expertise, and customer support in advancing medical innovation.
“We are thrilled to partner with a company as innovative and driven as CorTec,” said Toiné Warren, Executive Vice President, Commercial at Heraeus Medevio. “It is an opportunity to leverage each other’s expertise to provide a wider breadth of offerings to meet our customers’ needs in the neuromodulation space. This partnership with CorTec to exclusively manufacture their products positions us to bring forth the future of implantable technologies for our customers, driving our vision to improve 100 million lives every year forward.”
CorTec’s CEO, Dr. Oliver Baertl, shared the enthusiasm: “Partnering with Heraeus Medevio marks a decisive step in our mission to make the impossible possible for our customers. This cooperation allows Heraeus Medevio and us to combine our strengths. We can now ensure that our customers, regardless of size and location, have access to a complete suite of implantable solutions from prototype to large-scale production, all backed by the highest standards of quality and support.”
CTO Dr. Martin Schuettler adds, “This collaboration allows us to extend our engineering expertise across oceans, enhancing our offering with Heraeus Medevio’s large-scale production capabilities. Together, we’re not only bridging continents but also advancing the field of implantable technology as we will be able to deliver next-generation implantable components from the initial start of engineering up to the final series production. Our partnership and the cross-integration of technologies minimizes product development risks for our customers!”
Looking ahead, Medevio is expected to begin high-volume manufacturing of nerve cuff and paddle electrodes based on CorTec’s proprietary laser-micromachining technology by the end of 2025.
Go to the PDF download of this press release (English Version).
Go to the PDF download of this press release (German Version).
Media Contact:
Carolina Remke – Head of Marketing
pr@cortec-neuro.com
www.cortec-neuro.com
Fon.: +49 (0)761 70 888 200